Deep Vein Thrombosis Medication Recalled: Here’s What to Know Now

• A medication commonly used to treat deep vein thrombosis, Enoxaparin Sodium Injection, USP, has been voluntarily recalled due to a packaging error in which the labels don’t accurately list the correct dose.
• Taking the incorrect dose of the injection can lead to bleeding and clotting complications.
• Doctors don’t recommend skipping a dose, so if you have a bottle included in the recall, talk with your doctor immediately.

A medication commonly used to treat deep vein thrombosis, Enoxaparin Sodium Injection, USP, has been voluntarily recalled due to a packaging error in which the labels don’t accurately list the correct dose.

The recall, which was issued by pharmaceutical company Apotex Corp. Tuesday, Feb. 2, states that syringe barrels containing 150 mg/mL are mislabeled as containing 100mg/mL, and vice versa.

Enoxaparin sodium is an anticoagulant used to treat pulmonary embolism, blood clotting disorders, and deep vein thrombosis (DVT) — a condition in which blood clots form in veins located deep within the body.

When administered with aspirin, it can help prevent angina (chest pain) and heart attacks.

Taking the incorrect dose of the injection can lead to bleeding and clotting complications.

“Incorrect syringe barrel marking could lead to miscalculation and inaccurate dose administration to patients,” the recall states.